title: [Gemcitabine in the treatment of advanced non-small cell lung cancer: report of one case].
abstract: Gemcitabine is a newly developed drug for treating advanced non-small cell lung cancer (NSCLC). Adopting a treatment protocol combining gemcitabine and carboplatin, we succeeded in the management of 1 case of advanced NSCLC, and in this report the clinical status and findings by electron bronchoscopy of the patient were reported.
authors.affiliation: Department of Respiratory Diseases, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China.
authors.forename: Ai-Hua
authors.initials: AH
authors.lastname: Liu
authors.forename: Xin-Sheng
authors.initials: XS
authors.lastname: Wang
authors.forename: Ya
authors.initials: Y
authors.lastname: Zhou
authors.forename: E-Ying
authors.initials: EY
authors.lastname: Duan
authors.forename: Yue-Xian
authors.initials: YX
authors.lastname: Wu
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009367:Neoplasm Staging; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D016190:Carboplatin; D000093542:Gemcitabine